GenSight Biologics S.A. (EPA:SIGHT)
0.2280
+0.0020 (0.88%)
Apr 1, 2025, 2:16 PM CET
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of €28.97 million as of April 1, 2025. Its market cap has decreased by -15.34% in one year.
Market Cap
28.97M
Enterprise Value
45.62M
Revenue
2.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.23
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 28.97M, a decrease of -88.51%. That is a compound annual growth rate of -21.97%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sanofi | 126.57B |
EssilorLuxottica Société anonyme | 121.76B |
Sartorius Stedim Biotech | 18.06B |
bioMérieux | 13.73B |
Eurofins Scientific SE | 9.39B |
Ipsen | 8.84B |
Virbac | 2.52B |
emeis Société anonyme | 1.76B |